共 41 条
- [41] Reply to Juan Gomez Rivas, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low- risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36 EUROPEAN UROLOGY OPEN SCIENCE, 2022, 46 : 145 - 146